State Street’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$220M Buy
12,078,505
+637,727
+6% +$11.6M 0.01% 840
2025
Q1
$227M Sell
11,440,778
-3,429,969
-23% -$68.1M 0.01% 828
2024
Q4
$255M Buy
14,870,747
+1,865,754
+14% +$32M 0.01% 788
2024
Q3
$260M Buy
13,004,993
+4,945,063
+61% +$98.9M 0.01% 768
2024
Q2
$90.1M Sell
8,059,930
-2,493,423
-24% -$27.9M ﹤0.01% 1329
2024
Q1
$69.7M Buy
10,553,353
+1,069,763
+11% +$7.06M ﹤0.01% 1538
2023
Q4
$42.9M Sell
9,483,590
-118,348
-1% -$535K ﹤0.01% 1786
2023
Q3
$34.4M Sell
9,601,938
-911,965
-9% -$3.26M ﹤0.01% 1839
2023
Q2
$38.8M Sell
10,513,903
-2,474,686
-19% -$9.13M ﹤0.01% 1820
2023
Q1
$43M Buy
12,988,589
+1,981,380
+18% +$6.56M ﹤0.01% 1750
2022
Q4
$42.7M Buy
11,007,209
+1,583,787
+17% +$6.15M ﹤0.01% 1746
2022
Q3
$22.9M Buy
9,423,422
+6,459,197
+218% +$15.7M ﹤0.01% 2120
2022
Q2
$5.87M Buy
2,964,225
+2,330,710
+368% +$4.61M ﹤0.01% 3024
2022
Q1
$1.16M Buy
633,515
+219,271
+53% +$401K ﹤0.01% 3763
2021
Q4
$584K Hold
414,244
﹤0.01% 3963
2021
Q3
$468K Buy
414,244
+5,100
+1% +$5.76K ﹤0.01% 4005
2021
Q2
$655K Sell
409,144
-597,387
-59% -$956K ﹤0.01% 3761
2021
Q1
$1.77M Sell
1,006,531
-80,648
-7% -$142K ﹤0.01% 3482
2020
Q4
$2.12M Sell
1,087,179
-101,626
-9% -$198K ﹤0.01% 3350
2020
Q3
$2.84M Sell
1,188,805
-46,254
-4% -$111K ﹤0.01% 3058
2020
Q2
$3.62M Buy
1,235,059
+42,583
+4% +$125K ﹤0.01% 2924
2020
Q1
$3.43M Buy
1,192,476
+349,110
+41% +$1.01M ﹤0.01% 2812
2019
Q4
$3.37M Buy
843,366
+146,962
+21% +$588K ﹤0.01% 3036
2019
Q3
$3.1M Buy
696,404
+299,511
+75% +$1.33M ﹤0.01% 3038
2019
Q2
$1.54M Buy
396,893
+80,740
+26% +$312K ﹤0.01% 3333
2019
Q1
$1.2M Buy
316,153
+5,068
+2% +$19.2K ﹤0.01% 3304
2018
Q4
$743K Buy
311,085
+24,639
+9% +$58.8K ﹤0.01% 3383
2018
Q3
$1.78M Buy
286,446
+9,441
+3% +$58.7K ﹤0.01% 3289
2018
Q2
$1.25M Buy
+277,005
New +$1.25M ﹤0.01% 3373